1. Home
  2. SCLX vs BKTI Comparison

SCLX vs BKTI Comparison

Compare SCLX & BKTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • BKTI
  • Stock Information
  • Founded
  • SCLX 2011
  • BKTI 1997
  • Country
  • SCLX United States
  • BKTI United States
  • Employees
  • SCLX N/A
  • BKTI N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • BKTI Radio And Television Broadcasting And Communications Equipment
  • Sector
  • SCLX Health Care
  • BKTI Technology
  • Exchange
  • SCLX Nasdaq
  • BKTI Nasdaq
  • Market Cap
  • SCLX 81.7M
  • BKTI 117.0M
  • IPO Year
  • SCLX N/A
  • BKTI N/A
  • Fundamental
  • Price
  • SCLX $0.42
  • BKTI $36.66
  • Analyst Decision
  • SCLX Strong Buy
  • BKTI
  • Analyst Count
  • SCLX 3
  • BKTI 0
  • Target Price
  • SCLX $11.33
  • BKTI N/A
  • AVG Volume (30 Days)
  • SCLX 184.3K
  • BKTI 29.1K
  • Earning Date
  • SCLX 01-07-2025
  • BKTI 11-14-2024
  • Dividend Yield
  • SCLX N/A
  • BKTI N/A
  • EPS Growth
  • SCLX N/A
  • BKTI N/A
  • EPS
  • SCLX N/A
  • BKTI 1.39
  • Revenue
  • SCLX $50,833,000.00
  • BKTI $74,972,000.00
  • Revenue This Year
  • SCLX $32.77
  • BKTI $10.13
  • Revenue Next Year
  • SCLX $50.71
  • BKTI $25.00
  • P/E Ratio
  • SCLX N/A
  • BKTI $26.60
  • Revenue Growth
  • SCLX 9.41
  • BKTI N/A
  • 52 Week Low
  • SCLX $0.40
  • BKTI $11.06
  • 52 Week High
  • SCLX $2.63
  • BKTI $38.70
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 29.75
  • BKTI 58.23
  • Support Level
  • SCLX $0.43
  • BKTI $31.05
  • Resistance Level
  • SCLX $0.51
  • BKTI $38.70
  • Average True Range (ATR)
  • SCLX 0.06
  • BKTI 2.76
  • MACD
  • SCLX -0.01
  • BKTI -0.01
  • Stochastic Oscillator
  • SCLX 7.30
  • BKTI 78.56

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About BKTI BK Technologies Corporation

BK Technologies Corp a holding company, operates primarily through its subsidiary, BK Technologies, Inc., specializing in designing, manufacturing, and marketing wireless communications equipment. Its Radio business unit offers two-way land mobile radios (LMRs) serving government and public safety markets, as well as industrial and commercial enterprises. The SaaS business unit focuses on public safety smartphone applications, enhancing first responders' safety and efficiency. The BKRplay application, tethered to BK radios, amplifies user capabilities, expanding the reach of their radio sales. Its product portfolio consists of two-way land mobile radios, handheld radios, radios installed in vehicles.

Share on Social Networks: